- Home
- ZNTL vs VANI Comparison
ZNTL vs VANI Comparison
Compare ZNTL & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- VANI
- Stock Information
- Founded
- ZNTL 2014
- VANI 1998
- Country
- ZNTL United States
- VANI United States
- Employees
- ZNTL N/A
- VANI N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ZNTL Health Care
- VANI Health Care
- Exchange
- ZNTL Nasdaq
- VANI Nasdaq
- Market Cap
- ZNTL 105.8M
- VANI 88.3M
- IPO Year
- ZNTL 2020
- VANI 2014
- Fundamental
- Price
- ZNTL $1.34
- VANI $1.33
- Analyst Decision
- ZNTL Buy
- VANI Strong Buy
- Analyst Count
- ZNTL 7
- VANI 1
- Target Price
- ZNTL $8.60
- VANI $4.00
- AVG Volume (30 Days)
- ZNTL 772.3K
- VANI 121.4K
- Earning Date
- ZNTL 08-12-2025
- VANI 08-12-2025
- Dividend Yield
- ZNTL N/A
- VANI N/A
- EPS Growth
- ZNTL N/A
- VANI N/A
- EPS
- ZNTL N/A
- VANI N/A
- Revenue
- ZNTL $26,865,000.00
- VANI N/A
- Revenue This Year
- ZNTL N/A
- VANI N/A
- Revenue Next Year
- ZNTL N/A
- VANI N/A
- P/E Ratio
- ZNTL N/A
- VANI N/A
- Revenue Growth
- ZNTL N/A
- VANI N/A
- 52 Week Low
- ZNTL $1.01
- VANI $0.91
- 52 Week High
- ZNTL $5.44
- VANI $1.80
- Technical
- Relative Strength Index (RSI)
- ZNTL 46.92
- VANI 40.85
- Support Level
- ZNTL $1.34
- VANI $1.53
- Resistance Level
- ZNTL $1.48
- VANI $1.64
- Average True Range (ATR)
- ZNTL 0.08
- VANI 0.09
- MACD
- ZNTL -0.01
- VANI -0.03
- Stochastic Oscillator
- ZNTL 21.74
- VANI 7.44
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.